OBJECTIVE: To compare adult psychosocial functioning (PSF) of subjects with prepubertal major depressive disorder (PMDD) to a normal comparison (NC) group. METHOD: PSF of subjects with PMDD (n = 72) and of NC subjects (n = 28) was compared after prospective follow-up to adulthood. These 100 subjects were 90.9% of the baseline 110 subjects who participated in the "Nortriptyline in Childhood Depression: Follow-up Study." Research nurses who were blind to group status conducted telephone interviews using the Longitudinal Interval Follow-up Evaluation (LIFE) to obtain PSF data. RESULTS: At follow-up, the PMDD group was 20.7+/-2.0 and the NC subjects were 20.9+/-2.2 years old. The PMDD subjects were 10.3+/-1.5 years old at baseline. Time between baseline and follow-up was 9.9+/-1.5 years. In the PMDD group, subjects with MDD, bipolar disorder, or substance use disorders during the previous 5 years had significantly worse PSF than NC subjects. These PSF impairments included significantly worse relationships with parents, siblings, and friends; significantly worse functioning in household, school, and work settings; and worse overall quality of life and global social adjustment. CONCLUSIONS: Although combined treatments for PMDD have little scientific basis, multimodality regimens seem prudent until definitive treatment data become available.
RCT Entities:
OBJECTIVE: To compare adult psychosocial functioning (PSF) of subjects with prepubertal major depressive disorder (PMDD) to a normal comparison (NC) group. METHOD: PSF of subjects with PMDD (n = 72) and of NC subjects (n = 28) was compared after prospective follow-up to adulthood. These 100 subjects were 90.9% of the baseline 110 subjects who participated in the "Nortriptyline in Childhood Depression: Follow-up Study." Research nurses who were blind to group status conducted telephone interviews using the Longitudinal Interval Follow-up Evaluation (LIFE) to obtain PSF data. RESULTS: At follow-up, the PMDD group was 20.7+/-2.0 and the NC subjects were 20.9+/-2.2 years old. The PMDD subjects were 10.3+/-1.5 years old at baseline. Time between baseline and follow-up was 9.9+/-1.5 years. In the PMDD group, subjects with MDD, bipolar disorder, or substance use disorders during the previous 5 years had significantly worse PSF than NC subjects. These PSF impairments included significantly worse relationships with parents, siblings, and friends; significantly worse functioning in household, school, and work settings; and worse overall quality of life and global social adjustment. CONCLUSIONS: Although combined treatments for PMDD have little scientific basis, multimodality regimens seem prudent until definitive treatment data become available.
Authors: Laura J Dietz; Rebecca J Weinberg; David A Brent; Laura Mufson Journal: J Am Acad Child Adolesc Psychiatry Date: 2014-12-30 Impact factor: 8.829
Authors: Robert R Althoff; Frank C Verhulst; David C Rettew; James J Hudziak; Jan van der Ende Journal: J Am Acad Child Adolesc Psychiatry Date: 2010-11 Impact factor: 8.829
Authors: Robert Potter; Becky Mars; Olga Eyre; Sophie Legge; Tamsin Ford; Ruth Sellers; Nicholas Craddock; Frances Rice; Stephan Collishaw; Anita Thapar; Ajay K Thapar Journal: Br J Gen Pract Date: 2012-07 Impact factor: 5.386
Authors: Stephen V Faraone; Joel J Adamson; Timothy E Wilens; Michael C Monuteaux; Joseph Biederman Journal: Drug Alcohol Depend Date: 2007-09-04 Impact factor: 4.492
Authors: Boris Birmaher; David Axelson; Kelly Monk; Catherine Kalas; Benjamin Goldstein; Mary Beth Hickey; Mihaela Obreja; Mary Ehmann; Satish Iyengar; Wael Shamseddeen; David Kupfer; David Brent Journal: Arch Gen Psychiatry Date: 2009-03